Shareholders' Equity (Tables)

12 Months Ended

Dec. 31, 2019

Equity [Abstract]

Schedule of employees and directors stock option activity

	Number of options			Weighted average exercise price		Weighted average remaining contractual term (years)		Aggregate intrinsic value
Outstanding at January 1, 2019		6,474,982		$	2.28		3.39	$	4,475
Granted		2,760,500			1.90
Exercised		(470,899	)		1.58
Expired and forfeited		(1,464,916	)		2.59
Outstanding at December 31, 2019		7,299,667		$	2.12		3.81	$	-
Options vested and expected to vest at December 31, 2019		6,989,631		$	2.17		3.74	$	-
Exercisable options at December 31, 2019		3,797,668		$	2.27		2.48	$	-
Weighted average fair value of options granted during the year				$	0.72

Schedule of employee and directors options outstanding

Outstanding							Exercisable
Exercise			Weighted average remaining		Weighted average exercise				Weighted average exercise
price per	Options		contractual		price per		Options		price per
share	outstanding		life in years		share		exercisable		share
$1.44 - $1.93		2,376,531		4.38	$	1.62		951,031	$	1.57
$2.00 - $2.13		2,349,571		4.07	$	2.06		1,269,571	$	2.59
$2.14 - $2.75		1,106,701		4.25	$	2.37		426,543	$	2.34
$2.90 - $3.07		1,146,364		2.56	$	2.97		838,703	$	2.99
$3.20 - $3.32		320,500		.54	$	3.32		311,820	$	3.32
		7,299,667		3.81	$	2.16		3,797,668	$	2.45

Schedule of options to non-employees

Issuance date	Options outstanding		Exercise price per share		Options exercisable		Exercisable through
May 14, 2014		3,000	$	3.32		3,000	May-20
February 18, 2015		3,000	$	3.00		3,000	Feb-21
February 10, 2016		40,000	$	1.44		40,000	Feb-22
January 24, 2017		25,000	$	2.00		25,000	Jan-23
		71,000				71,000

Schedule of RSUs activity

	Number of RSUs			Weighted Average Grant Date Fair Value
Awarded and unvested at December 31, 2018		479,000		2.47
Granted		1,421,382		2.00
Vested		(126,000	)	2.42
Forfeited		(41,250	)	2.30
Awarded and unvested at December 31, 2019		1,733,132		2.09

Schedule of stock-based compensation expense

	Year ended December 31,
	2019		2018
Cost of revenues	$	241	$	174
Research and development		467		407
Sales and marketing		356		387
General and administrative		1,296		472
	$	2,360	$	1,440